Colonic Neoplasms: all 1,485 studies
Page 15 of 15. Open to participants first (362), then studies with results posted, then the rest; newest registration first within each.
- Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00303771Phase 3
- Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon CancerStatus unknownNCT00295035Phase 3
- IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and MelanomaStatus unknownNCT00294476Phase 2
- A Follow-up Colonoscopy Examination in Patients Who Had Previously Undergone Screening ColonoscopyCompletedNCT00280332
- MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon CancerCompletedNCT00275210Phase 3
- Molecular Genetic and Pathological Studies of Anal TumorsTerminatedNCT00267787
- Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By SurgeryCompletedNCT00265811Phase 3
- MASCOT : Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LVCompletedNCT00263055Phase 4
- GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon CancerCompletedNCT00262808Phase 2
- Resveratrol for Patients With Colon CancerCompletedNCT00256334Phase 1
- Evaluation of NiTi Laparoscopic Compression Anastomosis Clip (LapCAC) Device for Intra-Corporeal Lap-ColectomyStatus unknownNCT00250328Phase 1
- A Study of MLN8054 in Patients With Advanced Solid TumorsTerminatedNCT00249301Phase 1
- Clinical Trial in Patients With Metastatic Colorectal CancerCompletedNCT00235898Phase 2
- Comparative Study of Laparoscopic Versus Open Operations for Colon CancerStatus unknownNCT00202111Not applicable
- Study Evaluating Isovorin in Colon CancerCompletedNCT00195585Phase 3
- A Randomized Trial of Cancer Risk and Health Education in Relatives of Colorectal Cancer PatientsCompletedNCT00188305Phase 3
- Performance of the Water-Enema Computed Tomography (WE-CT)Status unknownNCT00188110Not applicable
- Imaging Colo-rectal Cancer Using a Two Step Antibody Technique in Nuclear ImagingCompletedNCT00185081Phase 1
- Study of Xeloda and Gleevec in Patients With Advanced Solid TumorsCompletedNCT00183833Phase 1
- A Prospective Single-Blinded Randomized Trial Comparing Colonoscopic Preparation at Different TimeCompletedNCT00155415Not applicable
- MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.TerminatedNCT00147550Phase 1/2
- Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid TumorsCompletedNCT00138177Phase 1
- Sorafenib, Cetuximab, and Irinotecan in Treating Patients With Advanced or Metastatic Colorectal CancerCompletedNCT00134069Phase 1
- Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to 5-Fluorouracil Based Chemotherapy in Stage III Colon CancerStatus unknownNCT00131599
- Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer TreatmentTerminatedNCT00126867
- Evaluation of Stool Tagging for Improved Patient ComplianceStatus unknownNCT00124163
- Colonoscopy or Fecal Occult Blood Test in Screening Healthy Participants for Colorectal CancerCompletedNCT00102011Phase 3
- Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerCompletedNCT00101348Phase 1/2
- Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon CancerStatus unknownNCT00091312Phase 3
- Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00089362Phase 1
- Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal CancerTerminatedNCT00088933Phase 1
- Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon CancerTerminatedNCT00087256Phase 3
- EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerTerminatedNCT00087191Not applicable
- GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid TumorsCompletedNCT00084643Phase 1
- Clinical Trial in Patients With Metastatic Colorectal CancerCompletedNCT00081627Phase 2
- Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal CancerCompletedNCT00077298Phase 2
- Study Evaluating EKB-569 in Advanced Colorectal CancerCompletedNCT00072748Phase 2
- Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal CancerTerminatedNCT00070265Phase 2
- Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal CancerTerminatedNCT00070122Phase 3
- Study Evaluating MAC-321 in Colorectal CancerCompletedNCT00063427Phase 2
- A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal CancerCompletedNCT00060411Phase 1
- Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.CompletedNCT00056459Phase 3
- Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal CancerCompletedNCT00056446Phase 3
- Genetic Study of Familial Factors in Patients With Colon CancerCompletedNCT00055848
- An Open Label Study of a Peptide Vaccine in Patients With Stage III Colon CancerCompletedNCT00054912Phase 1
- Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal CancerTerminatedNCT00052585Phase 2
- Combination Chemotherapy in Treating Patients With Colon CancerStatus unknownNCT00046995Phase 3
- Safety Study of hMN14 to Treat Either Colorectal or Breast CancerCompletedNCT00041652Phase 1/2
- Imatinib Mesylate in Treating Patients With Stage IV Colorectal CancerCompletedNCT00041340Phase 2
- Safety Study of 90Y-hMN14 to Treat Colorectal CancerCompletedNCT00040599Phase 1/2
- EPO906 Therapy in Patients With Advanced Colorectal CancerCompletedNCT00035087Phase 2
- Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal CancerCompletedNCT00032110Phase 2
- 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
- Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
- Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerCompletedNCT00028496Phase 1
- Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the LiverCompletedNCT00026234Phase 2
- Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously TreatedCompletedNCT00025337Phase 3
- Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal CancerCompletedNCT00023933Phase 1
- Vaccine Therapy in Treating Patients With Metastatic CancerCompletedNCT00020267Phase 1
- Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the LiverCompletedNCT00019760Phase 2
- Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung CancerCompletedNCT00019006Phase 1
- Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During SurgeryCompletedNCT00016133Phase 1/2
- Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon CancerCompletedNCT00005979Phase 3
- SU5416 and Irinotecan in Treating Patients With Advanced Colorectal CancerCompletedNCT00005818Phase 1/2
- Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove PolypsCompletedNCT00005094Phase 3
- Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerCompletedNCT00005036Phase 3
- Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon CancerCompletedNCT00004931Phase 3
- Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel ObstructionCompletedNCT00004911Phase 1/2
- High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon CancerCompletedNCT00004150Phase 3
- Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
- Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal CancerCompletedNCT00003873Phase 3
- Combination Chemotherapy in Treating Patients With Stage III Colon CancerCompletedNCT00003835Phase 3
- Gene Testing in Patients With Colon CancerCompletedNCT00003571
- Antineoplaston Therapy in Treating Patients With Colon CancerWithdrawnNCT00003486Phase 2
- Antineoplaston Therapy in Treating Patients With Metastatic or Unresectable Colon CancerTerminatedNCT00003485Phase 2
- Immunotherapy in Treating Patients With Resected Liver Metastases From Colon CancerCompletedNCT00003433Phase 1/2
- Radiation Therapy Plus Irinotecan in Treating Patients With Colon CancerCompletedNCT00003344Phase 1/2
- SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to FluorouracilCompletedNCT00003254Phase 2
- Edrecolomab in Treating Patients With Stage II Colon CancerCompletedNCT00002968Phase 3
- Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal CancerTerminatedNCT00002796Phase 1/2
- S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically RemovedCompletedNCT00002593Phase 3
- Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon CancerCompletedNCT00002575Phase 3
- Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or MelanomaStatus unknownNCT00002455Phase 3
- A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by RituximabCompletedNCT00001805Phase 2
- Women's Health Initiative (WHI)CompletedNCT00000611Phase 3